TB-500 (Thymosin Beta-4)

TB-500 is closely related to thymosin beta-4, a protein the body makes that occurs in almost all cells and is involved in tissue repair, cell migration and inflammation control. In a research context, TB-500 is used for regeneration, tendon and ligament health and mobility.

Unlike BPC-157, which people like to inject locally, TB-500 acts more systemically and distributes well through the body. It ships as a freeze-dried powder you dissolve in bacteriostatic water.

The compound binds actin, a central building block of the cell skeleton, and thereby supports the migration of repair and progenitor cells to a site of damage. On top come effects on the formation of new blood vessels and on dampening inflammation.

In a research context, thymosin beta-4 is studied for wound healing and heart tissue, among others. The effects are spread across the whole body, not just at the injection site.

For subcutaneous use you need:

• The TB-500 vial with the freeze-dried powder
• Bacteriostatic water to dissolve it
• U-100 insulin syringes
• Alcohol swabs for the vial cap and the skin
• A sealable sharps container for used needles

The powder is dissolved in bacteriostatic water. How much water you add sets the concentration, and with it how many units you draw for your dose on the insulin syringe.

Use the calculator above for this: pick your vial size and the water volume, and you see the concentration and units per dose.

When dissolving, just add the bac water, it does not matter if it hits the powder directly. Then swirl or shake until everything has dissolved, both are fine.

Because TB-500 acts systemically, the exact site matters less than with BPC-157. Classically it is injected subcutaneously into the abdomen.

• Clean the spot with an alcohol swab and let it dry
• Pinch up a small fold of skin
• Insert the needle at a 45 to 90 degree angle
• Inject slowly, wait a moment, then withdraw
• Put the needle straight into the sharps container

Rotate the site.

Thymosin beta-4 is well described mechanistically and was studied in early clinical approaches for wound healing and heart tissue. A review summarises structure, function and clinical potential. Large completed approval trials are missing, though, and TB-500 as a research form is not the same as an approved medicine. That belongs in the picture honestly.

The source with a link is in the source block below.

TB-500 is considered well tolerated. Mostly mild things are reported: injection-site reactions, occasionally brief tiredness after dosing. Solid long-term human safety data are limited, so phases make more sense than continuous running.

• Run it in phases: loading first, then maintenance, then a break.
• TB-500 is often combined with BPC-157: BPC more locally, TB-500 systemically.
• Sleep, protein and rest support the regeneration.

The undissolved powder is robust, normal room temperature (around 20 to 25 degrees) is fine, ideally kept in the dark. The reconstituted solution goes into the fridge (2 to 8 degrees) and stays stable there for at least 8 to 10 weeks with barely any loss of potency, in practice considerably longer. The bacteriostatic water brings a preservative that keeps the dissolved form stable for longer.